The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,998 | 152 | 11,159 | 13,833 | 19,286 |
| Depreciation Amortization | 18,739 | 15,779 | 4,082 | 2,085 | 987 |
| Income taxes - deferred | -26 | -263 | 183 | 131 | 180 |
| Accounts receivable | -6,141 | -20,285 | -15,215 | -9,200 | -4,660 |
| Accounts payable and accrued liabilities | 2,574 | -6,187 | -4,404 | -1,658 | -2,963 |
| Other Working Capital | -4,777 | -20,541 | -15,323 | -7,722 | -7,993 |
| Other Operating Activity | 4,177 | -30,411 | -28,241 | -24,829 | -21,818 |
| Operating Cash Flow | $-15,452 | $-61,756 | $-47,759 | $-27,360 | $-16,981 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,839 | -5,529 | -3,534 | -2,344 | -1,002 |
| Net Acquisitions | N/A | -8,577 | -8,107 | -8,920 | N/A |
| Purchase Of Investment | -9,759 | -117,508 | -87,402 | N/A | 0 |
| Sale Of Investment | 29,999 | N/A | 0 | N/A | N/A |
| Investing Cash Flow | $18,401 | $-131,614 | $-99,043 | $-11,264 | $-1,002 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 110,000 | 110,000 | N/A | N/A |
| Debt Repayment | -18 | -58 | -39 | -26 | -13 |
| Common Stock Issued | 0 | 858 | 416 | 337 | N/A |
| Common Stock Repurchased | N/A | -9,000 | -9,000 | -9,000 | N/A |
| Other Financing Activity | -1,691 | -9,594 | -8,324 | -3,653 | -1,644 |
| Financing Cash Flow | $-1,709 | $92,206 | $93,053 | $-12,342 | $-1,657 |
| Beginning Cash Position | 14,010 | 115,174 | 115,174 | 115,174 | 115,174 |
| End Cash Position | 15,250 | 14,010 | 61,425 | 64,208 | 95,534 |
| Net Cash Flow | $1,240 | $-101,164 | $-53,749 | $-50,966 | $-19,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,452 | -61,756 | -47,759 | -27,360 | -16,981 |
| Capital Expenditure | -1,839 | -5,529 | -3,534 | -2,344 | -1,002 |
| Free Cash Flow | -17,291 | -67,285 | -51,293 | -29,704 | -17,983 |